BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25850393)

  • 1. Reduced expression of miRNA-1237-3p associated with poor survival of spinal chordoma patients.
    Zou MX; Huang W; Wang XB; Li J; Lv GH; Wang B; Deng YW
    Eur Spine J; 2015 Aug; 24(8):1738-46. PubMed ID: 25850393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma.
    Zou MX; Huang W; Wang XB; Lv GH; Li J; Deng YW
    Int J Clin Exp Pathol; 2014; 7(8):4877-85. PubMed ID: 25197358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic implications of CD8
    Zou MX; Guo KM; Lv GH; Huang W; Li J; Wang XB; Jiang Y; She XL
    Cancer Immunol Immunother; 2018 Feb; 67(2):209-224. PubMed ID: 29051990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.
    Bayrak OF; Gulluoglu S; Aydemir E; Ture U; Acar H; Atalay B; Demir Z; Sevli S; Creighton CJ; Ittmann M; Sahin F; Ozen M
    J Neurooncol; 2013 Nov; 115(2):143-51. PubMed ID: 23912551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-155 expression is independently predictive of outcome in chordoma.
    Osaka E; Kelly AD; Spentzos D; Choy E; Yang X; Shen JK; Yang P; Mankin HJ; Hornicek FJ; Duan Z
    Oncotarget; 2015 Apr; 6(11):9125-39. PubMed ID: 25823817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA profiling and bioinformatics analyses reveal the potential roles of microRNAs in chordoma.
    Chen K; Chen H; Zhang K; Sun S; Mo J; Lu J; Qian Z; Yang H
    Oncol Lett; 2017 Nov; 14(5):5533-5539. PubMed ID: 29113181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram.
    Juracek J; Stanik M; Vesela P; Radova L; Dolezel J; Svoboda M; Slaby O
    Urol Oncol; 2019 Mar; 37(3):184.e1-184.e7. PubMed ID: 30446443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
    PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
    Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
    Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive role of dysregulated miRNAs in chordoma cancer stem-like cell maintenance.
    Tuysuz EC; Gulluoglu S; Yaltirik CK; Ozbey U; Kuskucu A; Çoban EA; Sahin F; Türe U; Bayrak OF
    Exp Cell Res; 2019 Jul; 380(1):9-19. PubMed ID: 30951707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated miRNA-mRNA analysis revealing the potential roles of miRNAs in chordomas.
    Long C; Jiang L; Wei F; Ma C; Zhou H; Yang S; Liu X; Liu Z
    PLoS One; 2013; 8(6):e66676. PubMed ID: 23826111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
    Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
    J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
    Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
    Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA analysis of gastric cancer patients from Saudi Arabian population.
    Bibi F; Naseer MI; Alvi SA; Yasir M; Jiman-Fatani AA; Sawan A; Abuzenadah AM; Al-Qahtani MH; Azhar EI
    BMC Genomics; 2016 Oct; 17(Suppl 9):751. PubMed ID: 27766962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma.
    Huang W; Yan YG; Wang WJ; Ouyang ZH; Li XL; Zhang TL; Wang XB; Wang B; Lv GH; Li J; Zou MX
    Front Oncol; 2020; 10():556902. PubMed ID: 33194623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
    Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
    BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal column chordoma: prognostic significance of clinical variables and T (brachyury) gene SNP rs2305089 for local recurrence and overall survival.
    Bettegowda C; Yip S; Lo SL; Fisher CG; Boriani S; Rhines LD; Wang JY; Lazary A; Gambarotti M; Wang WL; Luzzati A; Dekutoski MB; Bilsky MH; Chou D; Fehlings MG; McCarthy EF; Quraishi NA; Reynolds JJ; Sciubba DM; Williams RP; Wolinsky JP; Zadnik PL; Zhang M; Germscheid NM; Kalampoki V; Varga PP; Gokaslan ZL;
    Neuro Oncol; 2017 Mar; 19(3):405-413. PubMed ID: 27663388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
    Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
    Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
    Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
    Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.